Frequencies of side-effects observed in clinical studies and given in the tables as follows are defined according to the MedDRA frequency convention: very common (>1/10); common (>1/100, <1/10); uncommon (>1/1,000; <1/100), rare (>1/10,000, <1/1,000); very rare (<1/10,000), not known (cannot be estimated from available data). MedDRA version 12.0 was used for coding.
Methylprednisolone aceponate (Advantan) Cream 0.1%: See Table 1.

Methylprednisolone aceponate (Advantan) Ointment 0.1%: See Table 2.

Methylprednisolone aceponate (Advantan) Fatty Ointment 0.1%: See Table 3.

As with other corticoids for topical application, the following local side-effects may occur: skin atrophy, skin striae, application site folliculitis, hypertrichosis, telangiectasia, perioral dermatitis, skin discoloration, and allergic skin reactions to any of the ingredients of the formulations. Systemic effects due to absorption may occur when topical preparations containing corticoids are applied.
View ADR Reporting Link